The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease.

Stephen O'BrienRichard G KavanaghBrian W CareyMichael M MaherOwen J O'ConnorEmmet J Andrews

Published in: European radiology experimental (2018)

Myosteatosis was associated with increased hospital stay and increased 30-day hospital readmission rates on multivariate regression analysis. Sarcopenia and myosteatosis in IBD were not associated with clinically relevant postoperative complications.

Keyphrases

patients with inflammatory bowel disease
skeletal muscle
healthcare
acute care
patients undergoing
adverse drug
community dwelling
type diabetes
data analysis